Technical Analysis for GTG - Genetic Technologies Limited

Grade Last Price % Change Price Change
grade F 0.004 0.00% 0.000
GTG closed unchanged on Friday, December 6, 2019, on 17 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical GTG trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
Oversold Stochastic Weakness 0.00%
20 DMA Resistance Bearish 0.00%

Older signals for GTG ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Interactive chart

Profile

Genetic Technologies Limited is a molecular diagnostics company. The Company is engaged in the provision of molecular risk assessment for cancer. The Company offers predictive testing and assessment tools for physicians to manage women's health. The Company's lead product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The Company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/gynecologists (OBGYNs) and breast cancer risk assessment specialists, such as breast surgeons. The Company operates in Australia, the United States and Switzerland. The Company's subsidiaries include Genetic Technologies Corporation Pty. Ltd. and Phenogen Sciences Inc. Genetic Technologies Corporation Pty. Ltd. is engaged in genetic testing. The Company has launched the BREVAGen test across the United States through Phenogen Sciences Inc.
Medicine Biotechnology Cancer Clinical Medicine Imaging Breast Cancer Healthcare Professionals Medical Tests Molecular Diagnostics

Is GTG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.012
52 Week Low 0.004
Average Volume 6,078,426
200-Day Moving Average 0.006
50-Day Moving Average 0.005
20-Day Moving Average 0.004
10-Day Moving Average 0.004
Average True Range 0.001
ADX 39.11
+DI 38.235
-DI 6.863
Chandelier Exit (Long, 3 ATRs ) 0.003
Chandelier Exit (Short, 3 ATRs ) 0.006
Upper Bollinger Band 0.005
Lower Bollinger Band 0.004
Percent B (%b) 0.36
BandWidth 33.333
MACD Line 0.000
MACD Signal Line 0.000
MACD Histogram -0.0001
Fundamentals Value
Market Cap 9.74 Million
Num Shares 2.44 Billion
EPS 0.00
Price-to-Earnings (P/E) Ratio -1.00
Price-to-Sales 24.33
Price-to-Book 1.33
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.006
Resistance 3 (R3) 0.006 0.005 0.005
Resistance 2 (R2) 0.005 0.005 0.005 0.005
Resistance 1 (R1) 0.005 0.005 0.005 0.005 0.005
Pivot Point 0.004 0.004 0.004 0.004 0.004
Support 1 (S1) 0.004 0.004 0.004 0.004 0.003
Support 2 (S2) 0.003 0.004 0.003 0.003
Support 3 (S3) 0.003 0.003 0.003
Support 4 (S4) 0.003